News

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...
Researchers have developed a blood-based diagnostic method for multiple myeloma and its precursor conditions. The method ...
Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of ...
According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...
SCIENTISTS have discovered a new way to track blood cancer, even when traditional tests miss it. A whole-body MRI scan can ...
Giving patients a whole-body MRI scan can detect minuscule amounts of myeloma, also known as minimal residue disease, even ...
Red bone marrow is found primarily in the flat bones such as the hip, ribs, pelvic bones, spine, and shoulder bone—these are the areas that multiple myeloma most often affects.
The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.
Bisphosphonates are recommended for all patients with multiple myeloma, regardless of evidence of bone disease Zoledronic acid and pamidronate prevent osteopenia, lytic disease and fractures. Dosing ...